Loading...
•
Jun 30, 2022
Health Catalyst Q2 2022 Earnings Report
Reported strong financial performance, exceeding the mid-point of quarterly guidance for both revenue and Adjusted EBITDA.
Key Takeaways
Health Catalyst reported strong Q2 2022 financial results, exceeding revenue and Adjusted EBITDA guidance. However, the company revised down its revenue and Adjusted EBITDA outlook for the full year due to a challenging end market environment impacting bookings performance.
Total revenue was $70.633 million, an 18% increase year-over-year.
Technology revenue was $45.397 million, a 28% increase year-over-year.
Professional services revenue was $25.236 million, a 5% increase year-over-year.
Adjusted EBITDA was $1.999 million, a 20% increase year-over-year.
Revenue by Segment
Forward Guidance
For Q3 2022, Health Catalyst expects total revenue between $65.3 million and $68.3 million, and Adjusted EBITDA between $(6.0) million and $(4.0) million. For the full year 2022, the company expects total revenue between $271.5 million and $275.5 million, and Adjusted EBITDA between $(6.0) million and $(4.0) million.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...